These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 11260933)
1. Prescription drug prices: why do some pay more than others do? Frank RG Health Aff (Millwood); 2001; 20(2):115-28. PubMed ID: 11260933 [TBL] [Abstract][Full Text] [Related]
2. AMCP Guide to Pharmaceutical Payment Methods. AMCP Task Force on Drug Payment Methodologies J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611 [TBL] [Abstract][Full Text] [Related]
3. Do pharmaceutical prices respond to potential patient out-of-pocket expenses? Pavenik N Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303 [TBL] [Abstract][Full Text] [Related]
4. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0). Academy of Managed Care Pharmacy J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720 [TBL] [Abstract][Full Text] [Related]
5. Making medicines affordable: the price factor (position paper). American Public Health Association Am J Public Health; 2001 Mar; 91(3):486-90. PubMed ID: 11236429 [No Abstract] [Full Text] [Related]
6. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation. Raimond VC; Feldman WB; Rome BN; Kesselheim AS Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664 [TBL] [Abstract][Full Text] [Related]
7. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics. Mendoza RL J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950 [TBL] [Abstract][Full Text] [Related]
8. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. Kesselheim AS; Avorn J; Sarpatwari A JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619 [TBL] [Abstract][Full Text] [Related]
10. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
11. Prescription drug pricing: the consumer perspective. Searing A N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625 [No Abstract] [Full Text] [Related]
12. The association of insurance type with costs of dispensed drugs. Mott DA; Kreling DH Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015 [TBL] [Abstract][Full Text] [Related]
13. Impact of brand drug discount cards on private insurer, government and patient expenditures. Law MR; Chan FKI; Harrison M; Worthington HC CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357 [TBL] [Abstract][Full Text] [Related]
14. The effect of generic competition on the price of brand-name drugs. Lexchin J Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552 [TBL] [Abstract][Full Text] [Related]
15. Pricing pain: relief in sight on drug costs? J Am Health Policy; 1992; 2(6):28-31. PubMed ID: 10122415 [TBL] [Abstract][Full Text] [Related]
16. Prescription-drug prices. Frank RG N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294 [No Abstract] [Full Text] [Related]
17. Prescription drug benefits: Rx for cost management--commentary. Carlsen MA Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207 [No Abstract] [Full Text] [Related]
18. Government commitment and regulation of prescription drugs. Frank RG Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271 [TBL] [Abstract][Full Text] [Related]